| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
: Regions Required for Native Activity and Prostaglandin E2-Dependent Transactivation of Insulin-Like Growth Factor I Gene Expression in Rat Osteoblasts
Department of Surgery, Plastic Surgery Section, Yale University School of Medicine, New Haven, Connecticut 06520
Address all correspondence and requests for reprints to: Thomas L. McCarthy, Ph.D., Department of Surgery, Plastic Surgery Section, Yale University School of Medicine, P.O. Box 208041, New Haven, Connecticut 06520-8041. E-mail: thomas.mccarthy{at}yale.edu.
In osteoblasts, hormones such as prostaglandin E2 that activate protein kinase A increase the translocation of transcription factor CCAAT/enhancer binding protein 
(C/EBP) from the cytoplasm to the nucleus where it rapidly induces IGF-I gene expression. In this study, we identified activation and suppression domains in C/EBP using native and heterologous gene promoter assay systems. We demonstrated functional interactions between C/EBP and trans-gene-expressed cAMP response element binding protein-binding protein, and showed that the ability of C/EBP to promote gene expression was suppressed by viral protein E1A, which blocks the activity of native cAMP response element binding protein-binding protein. Site-directed mutations at serines 62 or 191 within C/EBP reduced its basal transcriptional activity, whereas mutation at serine 191 suppressed the stimulatory effect of prostaglandin E2 on C/EBP function as well as its DNA binding potential. These results are consistent with the location of serine 191 in the DNA binding domain of C/EBP. Our studies provide the first evidence for regions of C/EBP that are important for basal and for hormone-induced transcriptional activity, and for its interactions with other enhancers and suppressers of gene expression.
This article has been cited by other articles:
 |
|
 |
|
  I. Kijima, J. Ye, C. Glackin, and S. Chen CCAAT/Enhancer Binding Protein {delta} Up-regulates Aromatase Promoters I.3/II in Breast Cancer Epithelial Cells Cancer Res., June 1, 2008; 68(11): 4455 - 4464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. McCarthy, R. B. Hochberg, D. C. Labaree, and M. Centrella 3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts J. Biol. Chem., November 23, 2007; 282(47): 34003 - 34012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. McCauslin, V. Heath, A. M. Colangelo, R. Malik, S. Lee, A. Mallei, I. Mocchetti, and P. F. Johnson CAAT/Enhancer-binding Protein {delta} and cAMP-response Element-binding Protein Mediate Inducible Expression of the Nerve Growth Factor Gene in the Central Nervous System J. Biol. Chem., June 30, 2006; 281(26): 17681 - 17688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thangaraju, M. Rudelius, B. Bierie, M. Raffeld, S. Sharan, L. Hennighausen, A-M. Huang, and E. Sterneck C/EBP{delta} is a crucial regulator of pro-apoptotic gene expression during mammary gland involution Development, November 1, 2005; 132(21): 4675 - 4685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dhawan, X. Peng, A. L. M. Sutton, P. N. MacDonald, C. M. Croniger, C. Trautwein, M. Centrella, T. L. McCarthy, and S. Christakos Functional Cooperation between CCAAT/Enhancer-Binding Proteins and the Vitamin D Receptor in Regulation of 25-Hydroxyvitamin D3 24-Hydroxylase Mol. Cell. Biol., January 1, 2005; 25(1): 472 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy Fos-related Antigen 2 Controls Protein Kinase A-induced CCAAT/Enhancer-binding Protein {beta} Expression in Osteoblasts J. Biol. Chem., October 8, 2004; 279(41): 42438 - 42444. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
